As of 2024-12-13, the EV/EBITDA ratio of Microbix Biosystems Inc (MBX.TO) is 10.82. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MBX.TO's latest enterprise value is 40.33 mil CAD. MBX.TO's TTM EBITDA according to its financial statements is 3.73 mil CAD. Dividing these 2 quantities gives us the above MBX.TO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 10.8x | 10.8x |
| Forward P/E multiples | 15.7x - 15.7x | 15.7x |
| Fair Price | 0.34 - 0.35 | 0.34 |
| Upside | -0.1% - 0.1% | -0.0% |
| Date | EV/EBITDA |
| 2024-12-10 | 11.18 |
| 2024-12-09 | 11.00 |
| 2024-12-06 | 10.09 |
| 2024-12-05 | 10.27 |
| 2024-12-04 | 10.27 |
| 2024-12-03 | 10.27 |
| 2024-12-02 | 9.18 |
| 2024-11-29 | 9.36 |
| 2024-11-28 | 9.55 |
| 2024-11-27 | 9.73 |
| 2024-11-26 | 9.55 |
| 2024-11-25 | 9.55 |
| 2024-11-22 | 9.18 |
| 2024-11-21 | 9.18 |
| 2024-11-20 | 9.55 |
| 2024-11-19 | 9.73 |
| 2024-11-18 | 9.91 |
| 2024-11-15 | 9.73 |
| 2024-11-14 | 9.73 |
| 2024-11-13 | 9.55 |
| 2024-11-12 | 9.73 |
| 2024-11-11 | 9.73 |
| 2024-11-08 | 9.91 |
| 2024-11-07 | 9.73 |
| 2024-11-06 | 9.73 |
| 2024-11-05 | 9.73 |
| 2024-11-04 | 9.73 |
| 2024-11-01 | 9.91 |
| 2024-10-31 | 9.91 |
| 2024-10-30 | 9.73 |
| 2024-10-29 | 10.09 |
| 2024-10-28 | 10.09 |
| 2024-10-25 | 10.09 |
| 2024-10-24 | 10.27 |
| 2024-10-23 | 10.27 |
| 2024-10-22 | 10.64 |
| 2024-10-21 | 10.27 |
| 2024-10-18 | 10.45 |
| 2024-10-17 | 10.45 |
| 2024-10-16 | 10.45 |
| 2024-10-15 | 10.45 |
| 2024-10-11 | 10.45 |
| 2024-10-10 | 10.64 |
| 2024-10-09 | 10.82 |
| 2024-10-08 | 10.64 |
| 2024-10-07 | 10.45 |
| 2024-10-04 | 11.00 |
| 2024-10-03 | 11.18 |
| 2024-10-02 | 11.00 |
| 2024-10-01 | 10.64 |